Publication: Exendin-4 as a versatile therapeutic agent for the amelioration of diabetic changes
Loading...
Files
Program
KU-Authors
Organization Authors
Co-Authors
Ahmadi, Mahdi
Aslani, Somayeh
Saberianpour, Shirin
Rahbarghazi, Reza
Date
Language
Type
Embargo Status
NO
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic abnormality leading to microvascular and macrovascular complications. Non-insulin Incretin mimic synthetic peptide exendin-4 was introduced as an anti-diabetic drug which helped diabetic patients with triggering insulin secretion; further researches have revealed an effective role of exendin-4 in treatment of T2DM related diseases. Exendin-4 is approximately similar to Glucagon like peptide, thus it can bind to the glucagon-like peptide-1 receptor (GLP-1R) and activated different signaling pathways that are involved in various bioactivides such as apoptosis, insulin secretion and inactivation of microglial. In this review, we investigated the interesting role of exendin-4 in various kinds of T2DM related disorders through the activation of different signaling pathways.
Source
Publisher
Tabriz University of Medical Sciences
Subject
Citation
item.page.haspartof
Source
Advanced Pharmaceutical Bulletin
item.page.ispartofseries
item.page.edition
DOI
10.34172/apb.2022.025